FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2152548352> ?p ?o ?g. }

• W2152548352 endingPage "3208" @default.
• W2152548352 startingPage "3200" @default.
• W2152548352 abstract "Abstract Background: The targeted delivery of bioactive molecules with antibodies specific to tumor-associated antigens represents a promising strategy for improving the efficacy of tumor therapy. The large isoform of tenascin-C, an abundant glycoprotein of the tumor extracellular matrix, is strongly overexpressed in adult tissue undergoing tissue remodeling, including wound healing and neoplasia, and has been implicated in a variety of different cancers while being virtually undetectable in most normal adult tissues. Experimental Design: We have used antibody phage technology to generate good-quality human recombinant antibodies (F16 and P12) specific to the alternatively spliced domains A1 and D of the large isoform of tenascin-C. The tumor-targeting properties of F16 and P12 were assessed by biodistribution studies in tumor xenografts using the antibodies in small immunoprotein (SIP) format. Results: SIP(F16) selectively accumulated at the tumor site with 4.5%ID/g at 24 hours in the U87 glioblastoma model but was rapidly cleared from other organs (tumor-to-organ ratios, ∼10:1). The accumulation of SIP(P12) in the tumor was lower compared with SIP(F16) and persistent levels of radioactivity were observed in the intestine. Conclusions: These data suggest that the F16 antibody, specific to domain A1 of tenascin-C, is a promising building block for the development of antibody-based pharmaceuticals in view of its excellent tumor-targeting performance and the strong expression of the antigen in a variety of primary and metastatic tumors." @default.
• W2152548352 created "2016-06-24" @default.
• W2152548352 creator A5007432444 @default.
• W2152548352 creator A5020168745 @default.
• W2152548352 creator A5057328720 @default.
• W2152548352 creator A5071756866 @default.
• W2152548352 date "2006-05-15" @default.
• W2152548352 modified "2023-10-04" @default.
• W2152548352 title "Tumor-Targeting Properties of Novel Antibodies Specific to the Large Isoform of Tenascin-C" @default.
• W2152548352 cites W1512026049 @default.
• W2152548352 cites W1513872850 @default.
• W2152548352 cites W1581487302 @default.
• W2152548352 cites W1968704981 @default.
• W2152548352 cites W1992361137 @default.
• W2152548352 cites W2006187580 @default.
• W2152548352 cites W2008754002 @default.
• W2152548352 cites W2009507555 @default.
• W2152548352 cites W2011352832 @default.
• W2152548352 cites W2017092245 @default.
• W2152548352 cites W2017158341 @default.
• W2152548352 cites W2021122530 @default.
• W2152548352 cites W2022663306 @default.
• W2152548352 cites W2023115975 @default.
• W2152548352 cites W2025827008 @default.
• W2152548352 cites W2027136711 @default.
• W2152548352 cites W2031564147 @default.
• W2152548352 cites W2034982045 @default.
• W2152548352 cites W2043944189 @default.
• W2152548352 cites W2048313558 @default.
• W2152548352 cites W2056173512 @default.
• W2152548352 cites W2072202404 @default.
• W2152548352 cites W2074348188 @default.
• W2152548352 cites W2080955003 @default.
• W2152548352 cites W2083982805 @default.
• W2152548352 cites W2085881249 @default.
• W2152548352 cites W2087240594 @default.
• W2152548352 cites W2090841599 @default.
• W2152548352 cites W2103710418 @default.
• W2152548352 cites W2110287677 @default.
• W2152548352 cites W2111931758 @default.
• W2152548352 cites W2114849954 @default.
• W2152548352 cites W2130195637 @default.
• W2152548352 cites W2150408525 @default.
• W2152548352 cites W2154044013 @default.
• W2152548352 cites W2158106689 @default.
• W2152548352 cites W2160545140 @default.
• W2152548352 cites W2166269000 @default.
• W2152548352 cites W2175687390 @default.
• W2152548352 cites W2222528402 @default.
• W2152548352 cites W29053622 @default.
• W2152548352 cites W4236858784 @default.
• W2152548352 cites W4252608787 @default.
• W2152548352 doi "https://doi.org/10.1158/1078-0432.ccr-05-2804" @default.
• W2152548352 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16707621" @default.
• W2152548352 hasPublicationYear "2006" @default.
• W2152548352 type Work @default.
• W2152548352 sameAs 2152548352 @default.
• W2152548352 citedByCount "158" @default.
• W2152548352 countsByYear W21525483522012 @default.
• W2152548352 countsByYear W21525483522013 @default.
• W2152548352 countsByYear W21525483522014 @default.
• W2152548352 countsByYear W21525483522015 @default.
• W2152548352 countsByYear W21525483522016 @default.
• W2152548352 countsByYear W21525483522017 @default.
• W2152548352 countsByYear W21525483522018 @default.
• W2152548352 countsByYear W21525483522019 @default.
• W2152548352 countsByYear W21525483522020 @default.
• W2152548352 countsByYear W21525483522021 @default.
• W2152548352 countsByYear W21525483522022 @default.
• W2152548352 countsByYear W21525483522023 @default.
• W2152548352 crossrefType "journal-article" @default.
• W2152548352 hasAuthorship W2152548352A5007432444 @default.
• W2152548352 hasAuthorship W2152548352A5020168745 @default.
• W2152548352 hasAuthorship W2152548352A5057328720 @default.
• W2152548352 hasAuthorship W2152548352A5071756866 @default.
• W2152548352 hasBestOaLocation W21525483521 @default.
• W2152548352 hasConcept C117961784 @default.
• W2152548352 hasConcept C121608353 @default.
• W2152548352 hasConcept C126322002 @default.
• W2152548352 hasConcept C147483822 @default.
• W2152548352 hasConcept C159654299 @default.
• W2152548352 hasConcept C189165786 @default.
• W2152548352 hasConcept C203014093 @default.
• W2152548352 hasConcept C204232928 @default.
• W2152548352 hasConcept C2777738151 @default.
• W2152548352 hasConcept C2779256057 @default.
• W2152548352 hasConcept C502942594 @default.
• W2152548352 hasConcept C71924100 @default.
• W2152548352 hasConcept C86492073 @default.
• W2152548352 hasConcept C86803240 @default.
• W2152548352 hasConcept C95444343 @default.
• W2152548352 hasConceptScore W2152548352C117961784 @default.
• W2152548352 hasConceptScore W2152548352C121608353 @default.
• W2152548352 hasConceptScore W2152548352C126322002 @default.
• W2152548352 hasConceptScore W2152548352C147483822 @default.
• W2152548352 hasConceptScore W2152548352C159654299 @default.
• W2152548352 hasConceptScore W2152548352C189165786 @default.
• W2152548352 hasConceptScore W2152548352C203014093 @default.

• next